If you are aged 18 to 55 and have a confirmed diagnosis of relapsing-remitting multiple sclerosis (RRMS) with at least one relapse in the past 12 months, you may qualify for this study.
If you are 18 or older, have histologically confirmed follicular grade 1-3a non-Hodgkin's lymphoma, and have relapsed or progressive disease after at least one prior chemotherapy, you may qualify for this study.